Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -192.18% is 69% below its 3-year average of -113.46%, around the middle of its 3-year range (-259.44%–-36.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.04% below its 12-month average of -176.24%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -192.18%.
RETURN ON INVESTED CAPITAL (ROIC)
-192.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-176.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-114.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-113.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.04%
CURRENT VS 3Y AVG
-68.31%
CURRENT VS 5Y AVG
-69.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.27%
median of 721 covered companies
CURRENT VS SECTOR MEDIAN
-477.63%
vs the sector median at left
Genelux Corporation
Market Cap
$116.14M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-176.24%
3Y Avg
-114.18%
5Y Avg
-113.46%
Market Cap
$116.82M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$117.03M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$115.77M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$115.84M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
Market Cap
$118.36M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$114.20M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$113.01M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$121.73M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genelux Corporation (GNLX) | $116.14M | -192.18% | -176.24% | -114.18% | -113.46% |
| Coya Therapeutics, Inc. (COYA)vs › | $116.82M | -0.05% | -44.27% | -81.25% | -78.53% |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.03M | -87.72% | -74.88% | -52.32% | -62.32% |
| BGM Group Ltd. (BGM)vs › | $115.77M | -3.19% | -2.23% | -1.75% | 1.24% |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.84M | -145.10% | -158.49% | -239.94% | -201.97% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.36M | -61.84% | -30.30% | -57.06% | -116.42% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $114.20M | -44.81% | -53.33% | -46.90% | -39.65% |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | -19.83% | -23.34% | -19.01% | -18.39% |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.73M | -137.40% | -133.78% | -372.93% | -315.43% |
| Seer, Inc. (SEER)vs › | $121.23M | -28.87% | -28.06% | -25.36% | -20.47% |
ROIC
-192.2%
ROE
-209.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -192.18% |
| 2026-03-31 | -134.51% |
| 2025-12-31 | -259.44% |
| 2025-09-30 | -168.92% |
| 2025-06-30 | -126.14% |
| 2025-03-31 | -100.32% |
| 2024-12-31 | -112.63% |
| 2024-09-30 | -83.39% |
| 2024-06-30 | -69.37% |
| 2024-03-31 | -153.03% |
| 2023-12-31 | -113.24% |
| 2023-09-30 | -79.89% |
| 2023-06-30 | -36.55% |
| 2023-03-31 | -104.76% |
| 2020-12-31 | -380.16% |
